Xiangyu Yang
Guangzhou Municipal And Guangdong Provincial Key Laboratory Of Molecular Target & Clinical Pharmacology, The NMPA And State Key Laboratory Of Respiratory Disease
Guangzhou, 511436, China
Guangzhou, 511436, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Vilazodone inhibits NLRP3 inflammasome assembly by targeting the NACHT domain and alleviates inflammatory disease.
Journal: International immunopharmacology
Published: March 26, 2026
AXL enhances the self-renewal of cancer stem-like cells and Osimertinib chemoresistance by regulating SCD1 in non-small cell lung cancer.
Journal: Biochemical pharmacology
Published: February 09, 2025
Chlorquinaldol Alleviates Lung Fibrosis in Mice by Inhibiting Fibroblast Activation through Targeting Methionine Synthase Reductase.
Journal: ACS central science
Published: May 18, 2024
Gli1-mediated tumor cell-derived bFGF promotes tumor angiogenesis and pericyte coverage in non-small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 25, 2023
Reconstruction and Removal Mechanisms of Gel-like Membrane Fouling for Seawater Desalination: Experiments and Molecular Dynamics Simulations.
Journal: Polymers
Published: July 31, 2022
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice.
Journal: European journal of pharmacology
Published: March 21, 2022
Gli1 promotes epithelial-mesenchymal transition and metastasis of non-small cell lung carcinoma by regulating snail transcriptional activity and stability.
Journal: Acta pharmaceutica Sinica. B
Published: December 09, 2021
Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance.
Journal: Frontiers in chemistry
Published: July 21, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026